Skip to content

Treatment of Adult Men with High-risk Non-metastatic Castration-resistant Prostate Cancer

Living with Treatment of Adult Men with High-risk Non-metastatic Castration-resistant Prostate Cancer means managing a challenging set of symptoms. This page lists medicine types such as Enzalutamide that may be part of a wider care strategy. Products containing Enzalutamide feature in this group.

Xtandi

Enzalutamide

40mg

Blocks androgen receptors and inhibits androgen receptor signalling to slow prostate cancer growth and delay disease progression in adult men with prostate cancer.

From$19.02/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.